Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Corza Medical GmbH

Clinicaltrial registered10 Nov 2026

Corza Medical GmbH

10 Nov 2026: Trial registered · Effectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural Sealing Among Adult Inpatients. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
10 Nov 2026
Title
Effectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural Sealing Among Adult Inpatients
Conditions
Cerebrospinal Fluid (CSF) Leak, Psuedomeningocele
Study Type
Observational
Status
Recruiting
Countries
United States
Country
United States
Reference
NCT07927413
Location
United States
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Corza Medical GmbH

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from United States

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.